Related Experiment Videos
Less IS less: a randomised controlled trial comparing cautious and rapid nalbuphine dosing regimens.
M Woollard1, R Whitfield, K Smith
1Pre-hospital Emergency Research Unit, Welsh Ambulance Services NHS Trust/University of Wales College of Medicine, Cardiff, UK. Malcolm.woollard@ukgateway.net <Malcolm.woollard@ukgateway.net>
Emergency Medicine Journal : EMJ
|April 27, 2004
Summary
A rapid nalbuphine dosing regimen (10 mg increments) is more effective for pain relief than a cautious regimen (5 mg increments) with similar safety profiles. Further research is needed to optimize dosing for patients with significant pain.
Area of Science:
- Emergency Medicine
- Pharmacology
Background:
- Nalbuphine is an analgesic used by paramedics for pain management.
- Optimizing nalbuphine dosing is crucial for balancing efficacy and adverse events.
Purpose of the Study:
- To compare the analgesic effectiveness and safety of two nalbuphine dosing regimens administered by paramedics.
- To identify the optimal nalbuphine dosing strategy for patients experiencing chest pain or trauma.
Main Methods:
- A randomized study comparing a rapid nalbuphine regimen (10 mg over 30 seconds, repeated) with a cautious regimen (5 mg over two minutes, repeated).
- Data collection included pain scores, vital signs, and patient-reported side effects.
Main Results:
- The rapid nalbuphine regimen showed a statistically significant greater reduction in pain scores compared to the cautious regimen.
- Over half of patients in both groups still experienced significant pain upon hospital arrival.
- Drowsiness was reported more frequently in the rapid regimen group (42%) versus the cautious group (21%).
Conclusions:
- The rapid nalbuphine dosing regimen (10 mg increments) is more effective and equally safe as the cautious regimen (5 mg increments).
- Further investigation is warranted to explore higher maximum nalbuphine doses to improve pain management before hospital arrival.